{"version":"1.0","provider_name":"Breakthrough T1D","provider_url":"https:\/\/breakthrought1d.eu\/nl","author_name":"ylt-admin","author_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/","title":"Financiering voor onderzoek Daniel Pipeleers - Breakthrough T1D","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"rYHYYglpf0\"><a href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/\">Financiering voor onderzoek Daniel Pipeleers<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/financiering-voor-onderzoek-daniel-pipeleers\/embed\/#?secret=rYHYYglpf0\" width=\"600\" height=\"338\" title=\"&#8220;Financiering voor onderzoek Daniel Pipeleers&#8221; &#8212; Breakthrough T1D\" data-secret=\"rYHYYglpf0\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/breakthrought1d.eu\/nl\/wp-includes\/js\/wp-embed.min.js\n\/* ]]> *\/\n<\/script>\n","description":"Op de Breakthrough T1D Walk 2013 kon Breakthrough T1D bekend maken dat prof. dr. Daniel Pipeleers van de Vrije Universiteit Brussel samen met prof. dr. Bart Roep van het Leids Universitair Medisch Centrum en hun onderzoeksteams een Breakthrough T1D-beurs van 1.980.000 dollar krijgen voor onderzoek naar de ontwikkeling van ingekapselde b\u00e8tacellen die veilig en normaal [&hellip;]"}